Effects of RHAMM/HMMR-Selective Peptides on Survival of Breast Cancer Cells

Verfasser / Beitragende:
[N. Akent'eva, S. Shushanov, A. Kotel'nikov]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/5(2015-09-01), 658-661
Format:
Artikel (online)
ID: 605536147
LEADER caa a22 4500
001 605536147
003 CHVBK
005 20210128100851.0
007 cr unu---uuuuu
008 210128e20150901xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-3041-3  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-3041-3 
245 0 0 |a Effects of RHAMM/HMMR-Selective Peptides on Survival of Breast Cancer Cells  |h [Elektronische Daten]  |c [N. Akent'eva, S. Shushanov, A. Kotel'nikov] 
520 3 |a RHAMM-selective peptides in a concentration of 10 μg/ml (2×10-7 M) inhibited the growth of MDA-MB-231 breast cancer cells over 48 h. Treatment of cancer cells with RHAMM-selective peptides induced apoptosis and necrosis and increased caspase-3 activity (by 30%). 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a RHAMM-selective peptides  |2 nationallicence 
690 7 |a RHAMM/HMMR (hyaluronan-mediated motility receptor)  |2 nationallicence 
690 7 |a apoptosis  |2 nationallicence 
690 7 |a necrosis  |2 nationallicence 
690 7 |a breast cancer  |2 nationallicence 
700 1 |a Akent'eva  |D N.  |u Institute of Chemical Physics Problems, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russia  |4 aut 
700 1 |a Shushanov  |D S.  |u Research Institute of Carcinogenesis, N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia  |4 aut 
700 1 |a Kotel'nikov  |D A.  |u Institute of Chemical Physics Problems, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/5(2015-09-01), 658-661  |x 0007-4888  |q 159:5<658  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-3041-3  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-3041-3  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Akent'eva  |D N.  |u Institute of Chemical Physics Problems, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shushanov  |D S.  |u Research Institute of Carcinogenesis, N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kotel'nikov  |D A.  |u Institute of Chemical Physics Problems, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/5(2015-09-01), 658-661  |x 0007-4888  |q 159:5<658  |1 2015  |2 159  |o 10517